The epothilone dilemma

被引：20

作者：

de Jonge, M ^{[1
]}

Verweij, J ^{[1
]}

机构：

[1] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 36期

关键词：

D O I：

10.1200/JCO.2005.03.8844

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：9048 / 9050

页数：3

共 29 条

[1] Phase I trial and pharmacokinetic study of BMS-247550, an epothilone B analog, administered intravenously on a daily schedule for five days [J].

Abraham, J ;

Agrawal, M ;

Bakke, S ;

Rutt, A ;

Edgerly, M ;

Balis, FM ;

Widemann, B ;

Davis, L ;

Damle, B ;

Sonnichsen, D ;

Lebwohl, D ;

Bates, S ;

Kotz, H ;

Fojo, T .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (09) :1866-1873

[2]

AJANI JA, 2002, P AN M AM SOC CLIN, V21, pA155

[3] Role of body surface area in dosing of investigational anticancer agents in adults, 1991-2001 [J].

Baker, SD ;

Verweij, J ;

Rowinsky, EK ;

Donehower, RC ;

Schellens, JHM ;

Grochow, LB ;

Sparreboom, A .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2002, 94 (24) :1883-1888

[4] A phase II trial of the epothilone B analog, BMS-247550, in patients with previously treated advanced colorectal cancer [J].

Eng, C ;

Kindler, HL ;

Nattam, S ;

Ansari, RH ;

Kasza, K ;

Wade-Oliver, K ;

Vokes, EE .

ANNALS OF ONCOLOGY, 2004, 15 (06) :928-932

[5] Multi-institutional randomized phase II trial of the epothilone B analog ixabepilone (BMS-247550) with or without estramustine phosphate in patients with progressive castrate metastatic prostate cancer [J].

Galsky, MD ;

Small, EJ ;

Oh, WK ;

Chen, I ;

Smith, DC ;

Colevas, AD ;

Martone, L ;

Curley, T ;

DeLaCruz, A ;

Scher, HI ;

Kelly, WK .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (07) :1439-1446

[6] Epothilones: Mechanism of action and biologic activity [J].

Goodin, S ;

Kane, MP ;

Rubin, EH .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (10) :2015-2025

[7]

HAO D, 2002, P AN M AM SOC CLIN, V21, pA103

[8]

Hussain A, 2004, J CLIN ONCOL, V22, p397S

[9] Phase II clinical trial of ixabepilone (BMS-247550), an epothilone B analog, in metastatic and locally advanced breast cancer [J].

Low, JA ;

Wedam, SB ;

Lee, JJ ;

Berman, AW ;

Brufsky, A ;

Yang, SX ;

Poruchynsky, MS ;

Steinberg, SM ;

Mannan, N ;

Fojo, T ;

Swain, SM .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (12) :2726-2734

[10] The clinical development of new mitotic inhibitors that stabilize the microtubule [J].

Mani, S ;

Macapinlac, M ;

Goel, S ;

Verdier-Pinard, D ;

Fojo, T ;

Rothenberg, M ;

Colevas, D .

ANTI-CANCER DRUGS, 2004, 15 (06) :553-558

← 1 2 3 →